← Browse by Condition
Medical Condition
heart failure with preserved ejection fraction
Total Trials
9
Recruiting Now
9
Trial Phases
EARLY_Phase 1, Phase 3, Phase 4
ClinicalMetric tracks all active clinical trials for heart failure with preserved ejection fraction sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — heart failure with preserved ejection fraction Clinical Trials
How many clinical trials are currently recruiting for heart failure with preserved ejection fraction?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for heart failure with preserved ejection fraction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for heart failure with preserved ejection fraction?
heart failure with preserved ejection fraction research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a heart failure with preserved ejection fraction clinical trial?
Eligibility criteria for heart failure with preserved ejection fraction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05651919
Recruiting
Enrollment
175 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06992089
Recruiting
Enrollment
30 pts
Location
Spain
Sponsor
Fundación para la Investigació...
NCT05057806 EARLY_Phase 1
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
The University of Texas Health...
NCT07037459 Phase 3
Recruiting
Enrollment
5,056 pts
Location
United States, Argen...
Sponsor
Amgen
NCT06377761
Recruiting
Enrollment
80 pts
Location
China
Sponsor
Guangdong Provincial Hospital ...
NCT07918209
Recruiting
Enrollment
110 pts
Location
Poland
Sponsor
American Heart of Poland
NCT06249945 Phase 4
Recruiting
Enrollment
150 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...
NCT05991128 Phase 4
Recruiting
Enrollment
170 pts
Location
China
Sponsor
China-Japan Friendship Hospita...
NCT07202000 Phase 2
Recruiting
Enrollment
48 pts
Location
United States
Sponsor
Massachusetts General Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology